✦ LIBER ✦

Intensive chemotherapy with high dose epirubicin (EPI)in advanced breast cancer. the experience of the hellenic co-operative oncology group (HeCOG)

✍ Scribed by Athanassiadis, A.; Skarlos, D.; Kosmidis, P.; Giannakakis, Th.; Bafaloukos, D.; Kalogera-Fountzila, A.; Bamia, Ch.; Pavlidis, N.; Fountzilas, G.

Book ID: 122873890
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 126 KB
Volume: 30
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)90724-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose epirubicin and r-met-hu G-CSF

High-dose epirubicin and r-met-hu G-CSF (Filgrastim) in the treatment of patients with advanced breast cancer: A hellenic cooperative oncology group study

✍ Fountzilas, George ;Skarlos, Demosthenis ;Katsohis, Constantine ;Pavlidis, Nicho 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Neoadjuvant chemotherapy with standard v

Neoadjuvant chemotherapy with standard vs high dose of epirubicin plus filgrastim for locally advanced breast cancer. Report from the mexican oncology study group (MOSG)

✍ G. Morgan; C. Chan; J. Pott; L. Martignon; L. Perez-Michel; M. Ramírez; R. Zamor 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Paclitaxel and Carboplatin as Neoadjuvan

Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group

✍ Helen Gogas; Dimitrios Pectasides; Ioannis Kostopoulos; Evangelos Lianos; Dimost 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 847 KB

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group

✍ Pectasides, D.; Samantas, E.; Fountzilas, G.; Briasoulis, E.; Kosmidis, P.; Skar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 180 KB

0187 Weekly docetaxel with or without ge

0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

✍ F. Zagouri; A. Bamias; P. Papakostas; A. Karadimou; E. Bournakis; M. Dimopoulos; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

FEC versus sequential docetaxel followed

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

✍ Aristides Polyzos; Nikolaos Malamos; Ioannis Boukovinas; Adamos Adamou; Nikolaos 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 296 KB